|
시장보고서
상품코드
2055121
핵의학 소프트웨어 시장 : 유형별, 모달리티별, 치료 영역별, 도입 모델별, 통합 복잡성별, 가격 모델별, 최종사용자별, 지역별Nuclear Medicine Software Market, By Type, By Modality, By Therapeutic Area, By Deployment Model, By Integration Complexity, By Pricing Model, By End User, By Geography |
||||||
핵의학 소프트웨어 시장은 2026년에 10억 7,170만 달러로 추정되며, 2033년까지 19억 9,710만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 9.3%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 10억 7,170만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.30% | 2033년 시장 규모 예측 : | 19억 9,710만 달러 |
세계 핵의학 소프트웨어 시장은 급속히 발전하는 핵의학 및 분자 영상 분야를 뒷받침하는 중요한 기술적 기반이 되고 있습니다. 이 전문 소프트웨어는 SPECT, PET 및 하이브리드 영상 기법을 포함한 핵의학 영상 데이터의 획득, 처리, 분석 및 관리를 용이하게 하기 위해 설계된 종합적인 솔루션을 제공합니다.
핵의학 소프트웨어는 전 세계 의료 기관에서 진단 정확도 향상, 업무 흐름의 효율화, 그리고 임상적 의사 결정 지원에 있어 필수적인 역할을 수행하고 있습니다. 이 시장에는 이미지 재구성 소프트웨어, 정량 분석 도구, 보고서 작성 시스템, 통합형 병원 정보 관리 플랫폼 등 다양한 소프트웨어 카테고리가 포함됩니다.
의료 시스템에서 정밀 의학 및 맞춤형 치료에 대한 중요성이 커지는 가운데, 핵의학 소프트웨어는 첨단 분자 영상 기술과 방사성 의약품의 응용을 가능하게 하는 기반 요소로 부상해 왔습니다. 인공지능, 머신러닝 알고리즘, 클라우드 기반 플랫폼의 통합은 기존의 핵의학 진료에 혁명을 일으켜, 영상 품질 향상, 자동 분석 기능, 그리고 환자 처리 능력 향상을 실현하고 있습니다.
시장 역학
세계 핵의학 소프트웨어 시장은 몇 가지 강력한 촉진요인에 힘입어 견조한 성장세를 이어가고 있습니다. 특히 암과 심혈관 질환을 비롯한 만성 질환의 유병률 증가가 시장 확대의 주요 원동력이 되고 있습니다. 이는 의료진이 환자의 예후 개선 및 치료 계획 수립을 위해 고도의 진단 솔루션을 필요로 하기 때문입니다. PET/CT 및 SPECT/CT 시스템을 포함한 하이브리드 영상 기술의 도입이 확대됨에 따라, 복잡한 다중 모달 데이터를 통합하고 분석할 수 있는 고급 소프트웨어 플랫폼이 필요해지고 있으며, 이에 따라 종합적인 핵의학 소프트웨어 솔루션에 대한 수요가 증가하고 있습니다.
인공지능(AI)과 머신러닝 분야의 기술적 진보는 소프트웨어의 기능을 크게 향상시켜, 영상 분석의 자동화, 진단 정확도의 향상, 판독 시간 단축을 가능하게 하고 있습니다. 이로 인해 업무 효율성과 임상적 우수성을 추구하는 의료 기관들의 관심을 끌고 있습니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 그 중 하나는 첨단 핵의학 소프트웨어 시스템 도입에 따르는 막대한 비용으로, 이는 예산이 한정된 의료기관에 부담이 될 수 있습니다. 특히, 비용 효율성이 여전히 중요한 고려 사항인 신흥 시장에서는 이러한 경향이 두드러집니다. 또한, 기존 병원 정보 시스템과의 소프트웨어 통합이 복잡하고 규제 준수 요건이 까다로워 도입에 어려움을 초래할 수 있으며, 이로 인해 도입 일정이 지연되거나 운영 비용이 증가할 가능성이 있습니다.
고급 소프트웨어 플랫폼을 효과적으로 활용할 수 있는 숙련된 핵의학 전문가의 부족 또한 시장 성장을 저해하는 요인으로 작용하고 있습니다. 부족한 교육이나 전문 지식은 소프트웨어 활용 및 투자 대비 효과를 저해할 수 있기 때문입니다. 이러한 과제가 있음에도 불구하고, 정밀 의학 및 테라노스틱스 분야에서 핵의학의 응용이 확대됨에 따라 큰 기회가 생겨나고 있습니다. 이러한 분야에서 소프트웨어 플랫폼은 맞춤형 치료 접근법과 방사성 의약품 치료의 모니터링을 지원할 수 있습니다. 가치 기반 의료 제공 모델에 대한 관심이 높아지는 가운데, 소프트웨어 공급업체에게는 진단 효율성, 환자 처리 능력 및 임상 결과 측면에서 측정 가능한 개선을 보여주는 솔루션을 개발할 기회가 생기고 있습니다. 이를 통해 투자 비용의 정당화가 가능해지며, 다양한 의료 현장에서 시장 침투가 촉진될 것입니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 핵의학 소프트웨어 시장의 주요 기업 프로파일을 소개합니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 핵의학 소프트웨어 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 핵의학 소프트웨어 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 핵의학 소프트웨어 시장 : 유형별, 2021년-2033년
제5장 세계의 핵의학 소프트웨어 시장 : 모달리티별, 2021년-2033년
제6장 세계의 핵의학 소프트웨어 시장 : 치료 영역별, 2021년-2033년
제7장 세계의 핵의학 소프트웨어 시장 : 도입 모델별, 2021년-2033년
제8장 세계의 핵의학 소프트웨어 시장 : 통합 복잡성별, 2021년-2033년
제9장 세계의 핵의학 소프트웨어 시장 : 가격 모델별, 2021년-2033년
제10장 세계의 핵의학 소프트웨어 시장 : 최종사용자별, 2021년-2033년
제11장 세계의 핵의학 소프트웨어 시장 : 지역별, 2021년-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
LSH 26.06.22Nuclear Medicine Software Market is estimated to be valued at USD 1071.7 Mn in 2026 and is expected to reach USD 1,997.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1071.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.30% | 2033 Value Projection: | USD 1,997.1 Mn |
The global nuclear medicine software market represents a critical technological backbone supporting the rapidly evolving field of nuclear medicine and molecular imaging. This specialized software encompasses comprehensive solutions designed to facilitate the acquisition, processing, analysis, and management of nuclear medical imaging data, including SPECT, PET, and hybrid imaging modalities.
Nuclear medicine software plays an indispensable role in enhancing diagnostic accuracy, streamlining workflow efficiency, and supporting clinical decision-making across healthcare institutions worldwide. The market encompasses various software categories including image reconstruction software, quantitative analysis tools, reporting systems, and integrated hospital information management platforms.
As healthcare systems increasingly prioritize precision medicine and personalized treatment approaches, nuclear medicine software has emerged as a fundamental component enabling advanced molecular imaging techniques and radiopharmaceutical applications. The integration of artificial intelligence, machine learning algorithms, and cloud-based platforms has revolutionized traditional nuclear medicine practices, offering enhanced image quality, automated analysis capabilities, and improved patient throughput.
Market Dynamics
The global nuclear medicine software market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, with the increasing prevalence of chronic diseases, particularly cancer and cardiovascular disorders, serving as a primary catalyst for market expansion as healthcare providers seek advanced diagnostic solutions to improve patient outcomes and treatment planning. The growing adoption of hybrid imaging technologies, including PET/CT and SPECT/CT systems, necessitates sophisticated software platforms capable of handling complex multi-modal data integration and analysis, thereby driving demand for comprehensive nuclear medicine software solutions.
Technological advancements in artificial intelligence and machine learning are significantly enhancing software capabilities, enabling automated image analysis, improved diagnostic accuracy, and reduced interpretation time, which attracts healthcare institutions seeking operational efficiency and clinical excellence. However, the market faces notable restraints including substantial implementation costs associated with advanced nuclear medicine software systems, which can burden healthcare facilities with limited budgets, particularly in emerging markets where cost-sensitivity remains a critical consideration. Additionally, the complexity of software integration with existing hospital information systems and regulatory compliance requirements create implementation challenges that may delay adoption timelines and increase operational overhead.
The shortage of skilled nuclear medicine professionals capable of effectively utilizing advanced software platforms also constrains market growth, as inadequate training and expertise can limit software utilization and return on investment. Despite these challenges, significant opportunities emerge through the expanding applications of nuclear medicine in precision medicine and theranostics, where software platforms can support personalized treatment approaches and radiopharmaceutical therapy monitoring. The increasing focus on value-based healthcare delivery models creates opportunities for software vendors to develop solutions that demonstrate measurable improvements in diagnostic efficiency, patient throughput, and clinical outcomes, thereby justifying investment costs and driving market penetration across diverse healthcare settings.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global nuclear medicine software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems Corporation, Bracco Imaging S.p.A. (via Advanced Accelerator Applications), Hermes Medical Solutions AB, Segami Corporation, MIM Software Inc., Mirada Medical Ltd., INVIA Medical Imaging Solutions, Mediso Medical Imaging Systems, Nuclear Diagnostics AB, Sofie Biosciences Inc., PMOD Technologies LLC, and Xeleris
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global nuclear medicine software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine software market
Market Segmentation
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Patient Data Management Software
- Imaging and Visualization Software
- Analysis and Quantification Software
- Clinical Decision Support Software
- Dosimetry Software
- Workflow and Scheduling Software
- Treatment Planning Software
- Others (Artificial Intelligence (AI) and Analytics Software, etc.)
- Modality Insights (Revenue, USD Mn, 2021 - 2033)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Others (Planar Scintigraphy, hybrid systems)
- Therapeutic Area Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Gastroenterology
- Others (Orthopedics, Infectious disease imaging, etc.)
- Deployment Model Insights (Revenue, USD Mn, 2021 - 2033)
- On-Premise
- Cloud-Based
- Integration Complexity Insights (Revenue, USD Mn, 2021 - 2033)
- Standalone Software
- Integrated Software Solutions
- Pricing Model Insights (Revenue, USD Mn, 2021 - 2033)
- Subscription-based Pricing
- Perpetual License Pricing
- Usage-based Pricing (pay-per-use)
- Freemium or Trial-based Pricing
- Customized or Enterprise Pricing
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems Corporation
- Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Hermes Medical Solutions AB
- Segami Corporation
- MIM Software Inc.
- Mirada Medical Ltd.
- INVIA Medical Imaging Solutions
- Mediso Medical Imaging Systems
- Nuclear Diagnostics AB
- Sofie Biosciences Inc.
- PMOD Technologies LLC
- Xeleris
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Nuclear Medicine Software Market, By Type
- Global Nuclear Medicine Software Market, By Modality
- Global Nuclear Medicine Software Market, By Therapeutic Area
- Global Nuclear Medicine Software Market, By Deployment Model
- Global Nuclear Medicine Software Market, By Integration Complexity
- Global Nuclear Medicine Software Market, By Pricing Model
- Global Nuclear Medicine Software Market, By End User
- Global Nuclear Medicine Software Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Nuclear Medicine Software Market, By Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Patient Data Management Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Imaging and Visualization Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Analysis and Quantification Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Clinical Decision Support Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Dosimetry Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Workflow and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Treatment Planning Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Artificial Intelligence (AI) and Analytics Software, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Nuclear Medicine Software Market, By Modality, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Planar Scintigraphy, hybrid systems)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Nuclear Medicine Software Market, By Therapeutic Area, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Orthopedics, Infectious disease imaging, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Nuclear Medicine Software Market, By Deployment Model, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Nuclear Medicine Software Market, By Integration Complexity, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Standalone Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Integrated Software Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Nuclear Medicine Software Market, By Pricing Model, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Subscription-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Perpetual License Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Usage-based Pricing (pay-per-use)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Freemium or Trial-based Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Customized or Enterprise Pricing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
10. Global Nuclear Medicine Software Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
11. Global Nuclear Medicine Software Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Integration Complexity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pricing Model, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bracco Imaging S.p.A. (via Advanced Accelerator Applications)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hermes Medical Solutions AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Segami Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MIM Software Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mirada Medical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- INVIA Medical Imaging Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mediso Medical Imaging Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nuclear Diagnostics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sofie Biosciences Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PMOD Technologies LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Xeleris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
